The FDA has added a boxed warning to the label of diabetes drugs containing canagliflozin (Johnson & Johnson’s brand names Invokana and Invokamet) to warn that these drugs carry an elevated risk of leg and foot amputations.
Mesothelioma is a type of malignant cancer that affects the thin lining of the body’s internal organs. It has been known for decades that mesothelioma is the direct result of exposure to asbestos. In response, the federal government banned many asbestos-containing products, although even today many asbestos products are still sold legally, and workers are still exposed in older structures that contain asbestos. Sadly, mesothelioma deaths continue to rise across the United States.
Construction accidents often present the most complicated type of personal injury claims. It is not always easy to figure out who is liable for jobsite injuries. Many large construction projects involve multiple contractors and subcontractors, each of whom may claim they are not at fault. A recent case at UMass-Amherst presents issues of general contractor and subcontractor liability.
In the latest win for women claiming Johnson and Johnson’s talcum powder caused their ovarian cancers, a jury has awarded $110 million to a woman who developed ovarian cancer after four decades of using J&J’s Baby Powder and Shower to Shower Powder. The jury found that Johnson & Johnson ignored decades of scientific research linking talcum powder use with ovarian cancer, and failed to warn consumers of the risk.
A jury has returned a verdict of $20,000,000 for a New Jersey woman who has been in constant pain since receiving a vaginal mesh implant made by Johnson & Johnson’s Ethicon unit. The jury awarded $2.5 million in compensatory damages for pain, suffering, and economic loss, and $17.5 million in punitive damages to punish J&J and Ethicon for failing to warn about the risks of mesh implants.
On March 31, the U.S. Food and Drug Administration (FDA) Mylan’s voluntary recall of the popular EpiPen brand of auto-injector medical device used to treat patients with severe allergies. This announcement came nearly two weeks after a similar recall was issued for the same devices in seven other countries. The recalls were a direct response to consumer complaints that the devices failed to operate as marketed.
By Marilyn T. McGoldrick, Esq. Published on April 13, 2017 Class 1 Recall The FDA has announced a Class 1 Recall of the Zimmer Biomet Comprehensive Reverse Shoulder Humeral Tray (Model 115339) following reports that the devices are fracturing at a higher rate...
Call 888-341-1405 for a free consultation with a recognized leader in defective drug and personal injury litigation. You can also contact us online to tell us your story. By: Marilyn McGoldrick, Esq. Published on March 20, 2017 Aortic aneurysms and dissections have...
Recently, issues were raised concerning the results of a clinical trial for the blood thinning drug Xarelto. It was discovered that a medical device used during the study was faulty and was later recalled. The effect this may have had on the study is especially concerning as more than 13 million prescriptions have been written for the drug nationwide.
In 2014, the U.S. Food and Drug Administration (FDA) published a statement discouraging the use of power morcellators during procedures to remove uterine fibroids. As a result, many morcellator sellers ceased manufacturing the devices and their use has drastically declined. However, Olympus America Inc. recently launched a new bladeless morcellator that is meant to prevent the inadvertent spreading of cancerous cells. Despite these changes, the FDA required the company to include a warning on the device’s label explaining that the instrument has not been proven to reduce the risk of spreading cancer.
During the first part of the twentieth century, many construction companies began using carcinogenic asbestos fibers in their building materials, including drywall, insulation, and ceiling tiles. Unfortunately, it was several decades before the general public discovered the link between asbestos exposure and mesothelioma, an aggressive and often deadly form of cancer. Although companies have since discontinued using almost all materials that contain asbestos, many individuals continue to suffer from this illness as a result of asbestos exposure. Fortunately, in the last ten years, doctors have made great strides in treating mesothelioma.
The Judicial Panel for Multidistrict Litigation transferred all existing Invokana (canagliflozin) and Invokamet (canagliflozin/metformin) cases alleging ketoacidosis and kidney disease from federal courts across the country to the United States District Court for the District of New Jersey on December 7, 2016. A total of 55 cases alleging injuries from these diabetes drugs were transferred from Illinois, Kentucky, Minnesota, Missouri, Virginia and West Virginia to a consolidated docket before the Honorable Brian R. Martinotti.
Invokana and Invokamet are classified as sodium-glucose-cotransporter-2 drugs (a/k/a SGLT2 inhibitors). SGLT2s work by preventing the kidneys from reabsorbing blood sugar. This lets the sugar leave the body through the urine, and thereby lowers blood glucose levels. SGLT2s are prescribed for Type 2 diabetes.
